We performed IHC to examine the expression levels of LMP2, PSME1 and PSME2 in NACI-NSCLC tumor tissue samples before NACI, and to explore their prognostic value in patients with NACI-NSCLC. The gene discussed is PSME2; the disease is non-small cell lung carcinoma.